Wells Fargo
MDCX icon

Wells Fargo’s Medicus Pharma MDCX Stock Holding History

Wells Fargo’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89 Buy
4
+2
+100% +$35 ﹤0.01% 6655
2026
Q1 		$34 Hold
2
– – ﹤0.01% 6679
2025
Q4 		$115 Hold
2
– – ﹤0.01% 6418
2025
Q3 		$174 Hold
2
– – ﹤0.01% 6353
2025
Q2 		$224 Buy
+2
New +$399 ﹤0.01% 6436

Other funds holding MDCX

Interchange Capital Partners
Interchange Capital Partners Pittsburgh, Pennsylvania $598M AUM 31.79% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Sterling Investment Advisors (Pennsylvania)
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
May Hill Capital
May Hill Capital Cohasset, Massachusetts $510M AUM 23.75% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wilmington Savings Fund Society
Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return

Wells Fargo's MDCX Position: Q2 2026 in Review

Wells Fargo increased its Medicus Pharma (MDCX) stake by 100% in Q2 2026, buying an estimated $35 and bringing the position to 4 shares worth $89. The position accounts for ﹤0.01% of the portfolio, ranked #6655.

Wells Fargo first reported a position in MDCX in Q2 2025 and has held it in 5 quarters since. The position peaked at $224 in Q2 2025. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Wells Fargo held 4 shares of Medicus Pharma worth $89 as of Q2 2026.
  • Wells Fargo bought 2 Medicus Pharma shares in Q2 2026, an estimated $35.
  • Medicus Pharma made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6655 holding.
  • Wells Fargo first reported a position in Medicus Pharma in Q2 2025 and has held it in 5 quarters since.
  • Wells Fargo's Medicus Pharma position peaked at $224 in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.